Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|May 7, 2014
Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infectionYu-Ting Liao, Shu-Chen Kuo, Yi-Tzu Lee, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 10, 2018
Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective studySung-Hsi Huang, Shu-Wen Lin, Sui-Yuan Chang, et al.Scientific Reports|December 8, 2020
CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysisPing-Huai Wang, Shu-Yung Lin, Susan Shih-Jung Lee, et al.Experimental Cell Research|September 20, 2020
Tp0136 targets fibronectin (RGD)/Integrin β1 interactions promoting human microvascular endothelial cell migrationXi Luo, Shu-Wen Lin, Qiu-Yan Xu, et al.Drug Design, Development and Therapy|March 9, 2026
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Intravenous Vancomycin in Intracranial Hemorrhage Patients with External Ventricular Drains: Implications for Dosing and Therapeutic Drug MonitoringYu-Ju Tseng, Liang Juan, Chien-Chih Wu, et al.Advances in Therapy|May 14, 2024
Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological MalignanciesYu-Wen Wang, Hsin-An Hou, Chien-Chin Lin, et al.The Journal of Antimicrobial Chemotherapy|December 6, 2012
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort studyGregory A Eschenauer, Peggy L Carver, Shu-Wen Lin, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 12, 2025
The therapeutic impact of maximum chemotherapy possession days during three consecutive months in non-tuberculous mycobacterial lung disease: A real-world experiencePing-Huai Wang, Yu-Feng Wei, Chia-Jung Liu, et al.Plos One|February 20, 2014
Therapeutic drug monitoring and pharmacogenetic study of HIV-infected ethnic Chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapyKuan-Yeh Lee, Shu-Wen Lin, Hsin-Yun Sun, et al.Scientific Reports|November 25, 2017
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapySung-Hsi Huang, Shu-Wen Lin, Sui-Yuan Chang, et al.Pageof 10